Jacques Tapiero
Director/Board Member bei MCCORMICK & COMPANY, INCORPORATED
Vermögen: 2 Mio $ am 31.03.2024
Profil
Jacques Tapiero is an Independent Director at McCormick & Co., Inc. He is also a Director at Esteve Pharmaceuticals S.A.
and a Lead Director at Esteve Healthcare SL.
Additionally, he serves as a Member-Global Council at Thunderbird School of Global Management.
Previously, Jacques held positions such as Managing Director at Eli Lilly Sweden AB from 1993 to 1995, Senior Vice President & President-Emerging Markets at Eli Lilly & Co. from 1983 to 2014, President & General Manager at Eli Lilly do Brasil Ltda.
from 1995 to 1999, and President & General Manager at Lilly France SAS from 2000 to 2004.
Jacques obtained an MBA from Thunderbird School of Global Management in 1982.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 27.03.2024 | 27 755 ( 0,17% ) | 2 Mio $ | 31.03.2024 | |
| 27.03.2024 | 2 620 ( 0,00% ) | 201 242 $ | 31.03.2024 |
Aktive Positionen von Jacques Tapiero
| Unternehmen | Position | Beginn |
|---|---|---|
| MCCORMICK & COMPANY, INCORPORATED | Director/Board Member | 24.09.2012 |
| Thunderbird School of Global Management | Corporate Officer/Principal | 05.05.2011 |
Esteve Pharmaceuticals S.A.
 Esteve Pharmaceuticals S.A. Pharmaceuticals: OtherHealth Technology Esteve Pharmaceuticals S.A. operates as a global pharmaceutical company. It provides Ophthalmology and other Pathologies therapies. The company is headquartered in Barcelona, Spain. | Director/Board Member | - |
Esteve Healthcare SL
 Esteve Healthcare SL Pharmaceuticals: MajorHealth Technology Esteve Healthcare SL is a Spanish international specialty pharma company that has experienced significant growth in 2022, expanding its presence in Europe and beyond. Esteve Healthcare is based in Barcelona, ES, and has subsidiaries in Germany. The company has launched an inhaled treatment for off periods in Parkinson's disease and is collaborating with Medtronic to improve the pathway of patients with refractory cancer pain. The company was founded in 1929 by Antoni Esteve Subirana, and Staffan Schüberg has been the CEO of the company since 2019. | Director/Board Member | 01.12.2016 |
Ehemalige bekannte Positionen von Jacques Tapiero
| Unternehmen | Position | Ende |
|---|---|---|
| ELI LILLY AND COMPANY | Corporate Officer/Principal | 31.01.2014 |
Lilly France SAS
 Lilly France SAS Pharmaceuticals: GenericHealth Technology Lilly France SAS manufactures and supplies therapeutic products. The company is headquartered in Neuilly-sur-Seine, France. | Chief Executive Officer | 01.01.2004 |
Eli Lilly do Brasil Ltda.
 Eli Lilly do Brasil Ltda. Pharmaceuticals: MajorHealth Technology Eli Lilly do Brasil Ltda. manufactures medicines. Its products include medicines for cancer, diabetes, depression, osteoporosis, and others. The company was founded in 1944 and is headquartered in Sao Paulo, Brazil. | Chief Executive Officer | 01.01.1999 |
| Eli Lilly Sweden AB | Chief Executive Officer | 01.01.1995 |
Ausbildung von Jacques Tapiero
| Thunderbird School of Global Management | Masters Business Admin |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 2 |
|---|---|
| ELI LILLY AND COMPANY | Health Technology |
| MCCORMICK & COMPANY, INCORPORATED | Consumer Non-Durables |
| Private Unternehmen | 5 |
|---|---|
Eli Lilly do Brasil Ltda.
Eli Lilly do Brasil Ltda. Pharmaceuticals: MajorHealth Technology Eli Lilly do Brasil Ltda. manufactures medicines. Its products include medicines for cancer, diabetes, depression, osteoporosis, and others. The company was founded in 1944 and is headquartered in Sao Paulo, Brazil. | Health Technology |
Lilly France SAS
Lilly France SAS Pharmaceuticals: GenericHealth Technology Lilly France SAS manufactures and supplies therapeutic products. The company is headquartered in Neuilly-sur-Seine, France. | Health Technology |
| Eli Lilly Sweden AB | |
Esteve Pharmaceuticals S.A.
Esteve Pharmaceuticals S.A. Pharmaceuticals: OtherHealth Technology Esteve Pharmaceuticals S.A. operates as a global pharmaceutical company. It provides Ophthalmology and other Pathologies therapies. The company is headquartered in Barcelona, Spain. | Health Technology |
Esteve Healthcare SL
Esteve Healthcare SL Pharmaceuticals: MajorHealth Technology Esteve Healthcare SL is a Spanish international specialty pharma company that has experienced significant growth in 2022, expanding its presence in Europe and beyond. Esteve Healthcare is based in Barcelona, ES, and has subsidiaries in Germany. The company has launched an inhaled treatment for off periods in Parkinson's disease and is collaborating with Medtronic to improve the pathway of patients with refractory cancer pain. The company was founded in 1929 by Antoni Esteve Subirana, and Staffan Schüberg has been the CEO of the company since 2019. | Health Technology |
